α-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy

Diabetes

Volumn 46, Issue SUPPL. 2, 1997, Pages

  Ziegler, Dan ^a   Gries, F Arnold ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; PLACEBO; THIOCTIC ACID;

AUTONOMIC NEUROPATHY; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG SAFETY; HEART RATE VARIABILITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; OXIDATIVE STRESS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

EID: 0030884244     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.2.s62     Document Type: Conference Paper

References (38)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 122:561-568, 1995
2. Diabetes Control and Complications Trial (DCCT) Research Group: Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial. Ann Neurol 38:869-880, 1995
3. Kennedy WR, Navarro X, Goetz FC, Sutherland DER, Najarian JS: Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med 322:1031-1037, 1990
4. Ziegler D: Diagnosis and management of diabetic peripheral neuropathy. Diabetic Med 13:S34-S38, 1996
5. Ziegler D: Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis, and treatment. Diabetes Metab Rev 10:339-383, 1994
6. Ziegler D, Piolot R, Gries FA: The natural history of diabetic neuropathy is governed by the degree of glycaemic control: a 10-year prospective study in IDDM (Abstract). Diabetologia 39 (Suppl. 1):A35, 1996
7. Jenner P: Oxidative damage in neurodegenerative disease. Lancet 344:796-798, 1994
8. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412, 1991
9. Cameron NE, Cotter MA: The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. Diabetes Metab Rev 10:189-224, 1994
10. Collier A, Rumley A, Rumley AG, Paterson JR, Leach JP, Lowe GDO, Small M: Free radical activity and hemostatic factors in NIDDM patients with and without microalbuminuria. Diabetes 41:909-913, 1992
11. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA: Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 97:22-28, 1996
12. Yoshida K, Hirokawa J, Tagami S, Kawakami Y, Urata Y, Kondo T: Weakened cellular scavenging activity against oxidative stress in diabetes mellitus: regulation of glutathione synthesis and efflux. Diabetologia 38:201-210, 1995
13. Nourooz-Zadeh J, Tajaddini-Sarmadi J, McCarthy S, Betteridge DJ, Wolff SP: Elevated levels of authentic plasma hydroperoxides in NIDDM. Diabetes 44:1054-1058, 1995
14. Suzuki YJ, Tsuchiya M, Packer L: Thioctic acid and dihydrolipoic acid are novel antioxidants which interact with reactive oxygen species. Free Radic Res Comms 15:255-263, 1991
15. Nagamatsu M, Nickander KK, Schmelzer JD, Raya A, Wittrock DA, Tritschler H, Low PA: Lipoic acid improves nerve blood flow, reduces oxidative stress and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care 18:1160-1167, 1995
16. Nickander KK, McPhee BR, Low PA, Tritschler H: Alpha-lipoic acid: antioxidant potency against lipid peroxidation of neural tissues in vitro and implications for diabetic neuropathy. Free Radic Biol Med 21:631-639, 1996
17. Kihara M, Low PA: Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathy. Exp Neurol 132:180-185, 1994
18. Sachse G, Willms B: Efficacy of thioctic acid in the therapy of peripheral diabetic neuropathy. In Aspects of Autonomic Neuropathy in Diabetes. Gries FA, Freund HJ, Rabe F, Berger H, Eds. Horm Metab Res, Suppl. Series 9, New York, Thieme-Stratton, 1980, p. 105-108
19. Schulz B, Reichel G, Hüttl I, Zander E, Runge U: Zur Wirksamkeit der Thioctsäuretherapie bei Typ-I-Diabetikern. Wiss Z Ernst-Moritz-Arndt-Universität Greifswald, Medizinische Reihe 35:48-50, 1986
20. Jörg J, Metz F, Scharafinski H: Zur medikamentösen Behandlung der diabetischen Polyneuropathie mit der Alpha-Liponsäure oder Vitamin B-Präparaten. Nervenarzt 59:36-44, 1988
21. 1 bei der diabetischen Neuropathie. Diab Stoffw 2:443-448, 1993
22. Delcker A, Fischer P-A, Ulrich H: Randomisierte Studie Thioctsäure gegenüber Vitamin-B-Kombinationspräparat bei Patienten mit diabetischer Polyneuropathie unter besonderer Berücksichtigung des peripheren Nervensystems. In Neue biochemische, pharmakologische und klinische Erkenntnisse zur Thioctsäure. Borbe HO, Ulrich H, Eds. Frankfurt, Verlag, 1989, p. 335-344
23. Reschke B, Zeuzem S, Rosak C, Petzoldt R, Althoff P-H, Ulrich H, Schöffling K: Hochdosierte Langzeitbehandlung mit Thioctsäure bei der diabetischen Polyneuropathie: Ergebnisse einer kontrollierten, randomisierten Studie unter besonderer Berücksichtigung der autonomen Neuropathie. In Neue biochemische, pharmakologische und klinische Erkenntnisse zur Thioctsäure. Borbe HO, Ulrich H, Eds. Frankfurt, Verlag, 1989, p. 318-334
24. Cavalière D, Scorpiglione N, Belflglio M, Carinci F, Cubasso D, Labbrozzi D, Mari E, Massi Benedetti M, Pontano C, Tognoni G, Nicolucci A: Quality assessment of randomised clinical trials on medical treatment of diabetic neuropathy. Diabetes Nutr Metab 7:287-294, 1994
25. Freiman JA, Chalmers TC, Smith H, Kuebler RR: The importance of beta, the type II error, and sample size in the design and interpretation of the randomized controlled trial: survey of two sets of "negative" trials. In Medical Uses of Statistics. Bailar JC, Mosteller F, Eds. Boston, NEJM Books, 1992, p. 357-373
26. Altman DG, Bland JM: Absence of evidence is not evidence of absence. BMJ 311:485, 1995
27. Ziegler D, Hanefeld M, Ruhnau KJ, Meißner HP, Lobisch M, Schütte K, Gries FA, The ALADIN Study Group: Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant α-lipoic acid: a 3-week randomized controlled trial (ALADIN Study). Diabetologia 38:1425-1433, 1995
28. Young RJ, Ewing DJ, Clarke BF: A controlled trial of sorbinil, an aldose reductase inhibitor, in chronic painful diabetic neuropathy. Diabetes 32:938-942, 1983
29. Judzewitsch RG, Jaspan JB, Polonsky KS, Weinberg CR, Halter JB, Halar E, Pfeifer MA, Vukadinovic C, Bernstein L, Schneider M, Liang K-Y, Gabbay KH, Rubenstein AH, Porte D: Aldose reductase inhibition improves nerve conduction velocity in diabetic patients. N Engl J Med 308:119-125, 1983
30. Young RR, Shahani BT: Nerve conduction velocity in diabetes. N Engl J Med 308:190-191, 1983
31. Santiago JV, Sönksen PH, Boulton AJM, Macleod A, Beg M, Bochenek W, Graepel GJ, Gonen B, The Tolrestat Study Group: Withdrawal of the aldose reductase inhibitor tolrestat in patients with diabetic neuropathy: effect on nerve function. J Diabetes Complications 7:170-178, 1993
32. Ziegler D, Conrad F, Ulrich H, Reichel G, Schatz H, Gries FA, the DEKAN Study Group: Effects of treatment with the antioxidant α-lipoic acid on cardiac autonomie neuropathy in NIDDM patients: a 4-month randomized controlled multicenter trial (DEKAN Study). Diabetes Care 20:369-373, 1997
33. Ziegler D, Laux G, Dannehl K, Spüler M, Mühlen H, Mayer P, Gries FA: Assessment of cardiovascular autonomie function: age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses. Diabetic Med 9:166-175, 1992
34. Marfella R, Verrazzo G, Acampora R, La Marca C, Giunta R, Lucarelli C, Paolisso G, Ceriello A, Giugliano D: Glutathione reverses systemic hemodynamic changes induced by acute hyperglycemia in healthy subjects. Am J Physiol 268:E1167-E1173, 1995
35. Rösen P, Ballhausen T, Bloch W, Addicks K: Endothelial relaxation is disturbed by oxidative stress in the diabetic rat heart: influence of tocopherol as antioxidant. Diabetologia 38:1157-1168, 1995
36. Strödter D, Lehmann E, Lehmann U, Tritschler H-J, Bretzel RG, Federlin K: The influence of thioctic acid on metabolism and function of the diabetic heart. Diabetes Res Clin Pract 29:19-26, 1995
37. Peripheral Nerve Society: Diabetic polyneuropathy in controlled clinical trials: consensus report of the Peripheral Nerve Society. Ann Neurol 38:478-482, 1995
38. Pfeifer MA, Schumer MP: Clinical trials of diabetic neuropathy: past, present, and future. Diabetes 44:1355-1361, 1995